{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:46:31Z","timestamp":1793947591143,"version":"4.8.0"},"reference-count":180,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","award":["709613"],"award-info":[{"award-number":["709613"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.jconrel.2017.08.033","type":"journal-article","created":{"date-parts":[[2017,8,27]],"date-time":"2017-08-27T00:32:54Z","timestamp":1503793974000},"page":"306-332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":504,"special_numbering":"C","title":["Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases"],"prefix":"10.1016","volume":"264","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8192-6750","authenticated-orcid":false,"given":"Christos","family":"Tapeinos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Battaglini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1192-3647","authenticated-orcid":false,"given":"Gianni","family":"Ciofani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2017.08.033_bb0005","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0021-9797(68)90272-5","article-title":"Controlled growth of monodisperse silica spheres in the micron size range","volume":"26","author":"St\u00f6ber","year":"1968","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0010","doi-asserted-by":"crossref","first-page":"16014","DOI":"10.1038\/natrevmats.2016.14","article-title":"Analysis of nanoparticle delivery to tumours","volume":"1","author":"Wilhelm","year":"2016","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0015","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2016.108","article-title":"Cancer nanomedicine: progress, challenges and opportunities","volume":"17","author":"Shi","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0020","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s11883-010-0106-7","article-title":"Insights into atherosclerosis using nanotechnology","volume":"12","author":"Jayagopal","year":"2010","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0025","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nrd3578","article-title":"Perspectives and opportunities for nanomedicine in the management of atherosclerosis","volume":"10","author":"Lobatto","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0030","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nrendo.2015.35","article-title":"Cardiovascular disease: new nanomedicines for treating atherosclerotic plaques","volume":"11","author":"Sargent","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0035","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.2147\/IJN.S60853","article-title":"Antioxidative nanofullerol prevents intervertebral disk degeneration","author":"Yang","year":"2014","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0040","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/j.nano.2017.03.015","article-title":"Nanoparticle fullerol alleviates radiculopathy via NLRP3 inflammasome and neuropeptides","volume":"13","author":"Jin","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0045","doi-asserted-by":"crossref","first-page":"4411","DOI":"10.1021\/nl2025882","article-title":"Nanoparticles targeting the infarcted heart","volume":"11","author":"Dvir","year":"2011","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0050","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1039\/C4BM00441H","article-title":"Micro- and nanoparticles for treating cardiovascular disease","volume":"3","author":"Suarez","year":"2015","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0055","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jconrel.2011.08.017","article-title":"Transport of drugs across the blood\u2013brain barrier by nanoparticles","volume":"161","author":"Wohlfart","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0060","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","article-title":"Nanoparticle-mediated brain drug delivery: overcoming blood\u2013brain barrier to treat neurodegenerative diseases","volume":"235","author":"Saraiva","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0065","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2013.08.008","article-title":"Drug delivery to the central nervous system by polymeric nanoparticles: what do we know?","volume":"71","author":"Kreuter","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0070","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.addr.2011.12.006","article-title":"Polymeric nanoparticles for drug delivery to the central nervous system","volume":"64","author":"Patel","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0075","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1248\/bpb.34.945","article-title":"Niosomes: a controlled and novel drug delivery system","volume":"34","author":"Rajera","year":"2011","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0080","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7372306","article-title":"Niosomes as nanoparticular drug carriers: fundamentals and recent applications","volume":"2016","author":"Ag Seleci","year":"2016","journal-title":"J. Nanomater."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0085","first-page":"192","article-title":"European journal of Ejpmr Transfersomes: novel approach for intranasal delivery","volume":"4","author":"Chaurasia","year":"2017","journal-title":"Eur. J. Pharm. Rev. Artic. Eur. J. Pharm. Med. Res. Med. Res."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0090","doi-asserted-by":"crossref","first-page":"10938","DOI":"10.1021\/acs.chemrev.5b00046","article-title":"New developments in liposomal drug delivery","volume":"115","author":"Pattni","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0095","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1208\/s12248-012-9330-0","article-title":"Challenges in development of targeted liposomal therapeutics","volume":"14","author":"Sawant","year":"2012","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0100","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.trac.2015.12.016","article-title":"Solid lipid-based nanocarriers as efficient targeted drug and gene delivery systems","volume":"77","author":"Ezzati Nazhad Dolatabadi","year":"2016","journal-title":"TrAC - Trends Anal. Chem."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0105","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.nano.2015.09.004","article-title":"Nanostructured lipid carriers: promising drug delivery systems for future clinics","volume":"12","author":"Beloqui","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0110","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jconrel.2017.05.019","article-title":"Recent advancements in liposomes targeting strategies to cross blood-brain barrier (BBB) for the treatment of Alzheimer's disease","volume":"260","author":"Agrawal","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0115","first-page":"5381","article-title":"Getting into the brain: liposome-based strategies for effective drug delivery across the blood \u2013 brain barrier","author":"Gamarra","year":"2016","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0120","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/816103","article-title":"Niosomes of ascorbic acid and \u03b1-tocopherol in the cerebral ischemia-reperfusion model in male rats","volume":"2014","author":"Varshosaz","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0125","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3109\/03639045.2011.608191","article-title":"Nanostructure-based drug delivery systems for brain targeting","volume":"38","author":"Haque","year":"2012","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/469679","article-title":"Liposomes for targeted delivery of active agents against neurodegenerative diseases (Alzheimer's disease and Parkinson's disease)","volume":"2011","author":"Spuch","year":"2011","journal-title":"J. Drug Deliv."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0135","series-title":"Method for Producing Solid Lipid Microspheres Having a Narrow Size Distribution, US005250236A","author":"Gasco","year":"1993"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0140","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.addr.2007.05.004","article-title":"Lipid nanoparticles: perspectives and challenges","volume":"59","author":"Gasco","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0145","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0939-6411(00)00087-4","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art","volume":"50","author":"M\u00fcller","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0150","doi-asserted-by":"crossref","first-page":"305","DOI":"10.15171\/apb.2015.043","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers: structure preparation and application","volume":"5","author":"Naseri","year":"2015","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0155","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.canlet.2012.07.006","article-title":"A critical review of lipid-based nanoparticles for taxane delivery","volume":"334","author":"Feng","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0160","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0378-5173(02)00180-1","article-title":"Nanostructured lipid matrices for improved microencapsulation of drugs","volume":"242","author":"Muller","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0165","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejps.2012.05.010","article-title":"Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?","volume":"47","author":"Das","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0170","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3109\/03639040903264397","article-title":"Formulation and characterization of bufadienolides-loaded nanostructured lipid carriers","volume":"36","author":"Li","year":"2010","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0175","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1517\/17425247.2014.945416","article-title":"Optimization of nanostructured lipid carriers of lamotrigine for brain delivery: in vitro characterization and in vivo efficacy in epilepsy","volume":"12","author":"Alam","year":"2015","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0180","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ijpharm.2011.07.040","article-title":"Development of an itraconazole-loaded nanostructured lipid carrier (NLC) formulation for pulmonary application","volume":"419","author":"Pardeike","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0185","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.addr.2012.09.021","article-title":"Solid lipid nanoparticles","volume":"64","author":"Mehnert","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0190","first-page":"211","article-title":"Production of solid lipid nanoparticles-drug loading and release mechanism","volume":"2","author":"Parhi","year":"2010","journal-title":"J. Chem. Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0195","doi-asserted-by":"crossref","DOI":"10.17795\/jjnpp-33968","article-title":"Superoxide dismutase-loaded solid lipid nanoparticles prepared by cold homogenization method: characterization and permeation study through burned rat skin","volume":"11","author":"Karami","year":"2016","journal-title":"Jundishapur J. Nat. Pharm. Prod."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0200","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jconrel.2015.06.002","article-title":"PLGA nanoparticles prepared by nano-emulsion templating using low-energy methods as efficient nanocarriers for drug delivery across the blood\u2013brain barrier","volume":"211","author":"Fornaguera","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0205","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejpb.2009.09.003","article-title":"Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: influence of the formulation parameters","volume":"74","author":"Gelperina","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2017.03.022","article-title":"Functionalised collagen spheres reduce H2O2 mediated apoptosis by scavenging overexpressed ROS","author":"Tapeinos","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0215","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.nano.2012.03.003","article-title":"Increased brain uptake of docetaxel and ketoconazole loaded folate-grafted solid lipid nanoparticles","volume":"9","author":"Venishetty","year":"2013","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0220","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1208\/s12249-012-9862-8","article-title":"The improvement of the anticancer effect of a novel compound benzoic acid, 2-hydroxy-, 2-D-ribofuranosylhydrazide (BHR) loaded in solid lipid nanoparticles","volume":"13","author":"Wang","year":"2012","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0225","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.dib.2015.11.038","article-title":"Optimization of solid lipid nanoparticles prepared by a single emulsification-solvent evaporation method","volume":"6","author":"Pooja","year":"2016","journal-title":"Data Br."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0230","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ajps.2016.01.001","article-title":"Spray drying of fenofibrate loaded nanostructured lipid carriers","volume":"11","author":"Xia","year":"2016","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0235","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0939-6411(97)00172-0","article-title":"Spray-drying of solid lipid nanoparticles (SLNTM)","volume":"46","author":"M.","year":"1998","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0240","article-title":"Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for pulmonary application : a review of the state of the art","author":"Weber","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0245","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.supflu.2013.05.020","article-title":"Lipid nanoparticles production by supercritical fluid assisted emulsion \u2013 diffusion","volume":"82","author":"Campardelli","year":"2013","journal-title":"J. Supercrit. Fluids"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0250","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3109\/02652048.2011.590615","article-title":"Formulation of curcumin-loaded solid lipid nanoparticles produced by fatty acids coacervation technique","volume":"28","author":"Chirio","year":"2011","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0255","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.colsurfb.2016.08.019","article-title":"Sustained release profile of quatro stimuli nanocontainers as a multi sensitive vehicle exploiting cancer characteristics","volume":"148","author":"Tapeinos","year":"2016","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2013.11.037","article-title":"Dynamic in vivo imaging of dual-triggered microspheres for sustained release applications: synthesis, characterization and cytotoxicity study","volume":"461","author":"Efthimiadou","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0265","doi-asserted-by":"crossref","DOI":"10.1111\/j.1551-2916.2007.02240.x","article-title":"Synthesis and characterization of magnetic nanocontainers","volume":"91","author":"Tapeinos","year":"2008","journal-title":"J. Am. Ceram. Soc."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0270","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nmat3776","article-title":"Stimuli-responsive nanocarriers for drug delivery","volume":"12","author":"Mura","year":"2013","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0275","doi-asserted-by":"crossref","first-page":"9604","DOI":"10.1039\/C6RA00423G","article-title":"An acetal-based polymeric crosslinker with controlled pH-sensitivity","volume":"6","author":"Cao","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0280","doi-asserted-by":"crossref","DOI":"10.1007\/s11051-011-0579-5","article-title":"New approach in synthesis, characterization and release study of pH-sensitive polymeric micelles, based on PLA-Lys-b-PEGm, conjugated with doxorubicin","volume":"13","author":"Efthimiadou","year":"2011","journal-title":"J. Nanopart. Res."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0285","doi-asserted-by":"crossref","first-page":"5553","DOI":"10.1002\/adma.201505376","article-title":"Physical, chemical, and biological structures based on ROS-sensitive moieties that are able to respond to oxidative microenvironments","volume":"28","author":"Tapeinos","year":"2016","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0290","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.msec.2014.01.024","article-title":"PH- and thermo-responsive microcontainers as potential drug delivery systems: morphological characteristic, release and cytotoxicity studies","volume":"37","author":"Efthimiadou","year":"2014","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0295","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1039\/C2TB00013J","article-title":"Microspheres as therapeutic delivery agents: synthesis and biological evaluation of pH responsiveness","author":"Tapeinos","year":"2013","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0300","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.colsurfb.2017.07.081","article-title":"Synthesis and characterization of hyaluronic acid coated manganese dioxide microparticles that act as ROS scavengers","volume":"159","author":"Bizeau","year":"2017","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/238428","article-title":"Nanoparticles for brain drug delivery","volume":"2013","author":"Masserini","year":"2013","journal-title":"ISRN Biochem."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0310","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/j.1755-5949.2010.00199.x","article-title":"Nanoparticulate Systems for Drug Delivery and Targeting to the central nervous system","volume":"17","author":"Craparo","year":"2011","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0315","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s11095-010-0141-7","article-title":"Nanoparticle-mediated brain-specific drug delivery, imaging, and diagnosis","volume":"27","author":"Yang","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0320","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2013.00157","article-title":"The potential of polymeric micelles in the context of glioblastoma therapy","volume":"4","author":"Morshed","year":"2013","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0325","series-title":"Handbook of Polymers for Pharmaceutical Technologies","year":"2015"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnagi.2015.00020","article-title":"Retinoic acid-loaded polymeric nanoparticles induce neuroprotection in a mouse model for Parkinson's disease","volume":"7","author":"Esteves","year":"2015","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0335","doi-asserted-by":"crossref","DOI":"10.3390\/ph9030054","article-title":"Preparation of temozolomide-loaded nanoparticles for glioblastoma multiforme targeting-ideal versus reality","volume":"9","author":"Lee","year":"2016","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0340","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.neulet.2015.06.049","article-title":"Peptide-functionalized polymeric nanoparticles for active targeting of damaged tissue in animals with experimental autoimmune encephalomyelitis","volume":"602","author":"F\u00fchrmann","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0345","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.2147\/IJN.S87148","article-title":"Nanotechnology-based drug delivery systems for the treatment of Alzheimer's disease","volume":"10","author":"Fonseca-santos","year":"2015","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0350","article-title":"Biomaterials for the treatment of Alzheimer's disease","volume":"4","author":"Hadavi","year":"2016","journal-title":"Front. Bioeng. Bioteechnol."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0355","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.2217\/nnm.14.130","article-title":"Applications of dendrimers for brain delivery and cancer therapy","volume":"9","author":"Somani","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0360","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4103\/0975-7406.130965","article-title":"Dendrimers in drug delivery and targeting: drug-dendrimer interactions and toxicity issues","volume":"6","author":"Pandita","year":"2014","journal-title":"J. Pharm. Bioallied Sci."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0365","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1021\/cn400182z","article-title":"Dendrimer advances for the central nervous system delivery of therapeutics","volume":"5","author":"Xu","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0370","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jcis.2015.03.019","article-title":"CREKA peptide-conjugated dendrimer nanoparticles for glioblastoma multiforme delivery","volume":"450","author":"Zhao","year":"2015","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0375","doi-asserted-by":"crossref","first-page":"576","DOI":"10.2174\/187152711796235023","article-title":"Dendrimers as novel systems for delivery of neuropharmaceuticals to the brain","volume":"10","author":"Beg","year":"2011","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2017.00166","article-title":"Targeted nanotechnology in glioblastoma multiforme","volume":"8","author":"Glaser","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0385","first-page":"76","article-title":"Multifunctional inorganic nanoparticles: recent progress in thermal therapy and imaging","volume":"6","author":"Cherukula","year":"2016","journal-title":"Nano"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0390","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1208\/s12248-015-9780-2","article-title":"A review of clinical translation of inorganic nanoparticles","volume":"17","author":"Anselmo","year":"2015","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fchem.2014.00109","article-title":"The application of magnetic nanoparticles for the treatment of brain tumors","volume":"2","author":"Mahmoudi","year":"2014","journal-title":"Front. Chem."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0400","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1186\/1556-276X-9-538","article-title":"Potential applications of magnetic particles to detect and treat Alzheimer's disease","volume":"9","author":"Busquets","year":"2014","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0405","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062425","article-title":"Selective targeting of brain tumors with gold nanoparticle-induced radiosensitization","volume":"8","author":"Joh","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0410","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/chem.201404562","article-title":"Gold-nanoparticle-based multifunctional amyloid-\u03b2 inhibitor against Alzheimer's disease","volume":"21","author":"Gao","year":"2015","journal-title":"Chem. - A Eur. J."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0415","doi-asserted-by":"crossref","first-page":"11039","DOI":"10.1002\/anie.201203780","article-title":"Ceria nanoparticles that can protect against ischemic stroke","volume":"51","author":"Kim","year":"2012","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0420","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.biochi.2011.05.005","article-title":"Functional lipids and lipoplexes for improved gene delivery","volume":"94","author":"Zhang","year":"2012","journal-title":"Biochimie"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0425","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2796.2009.02189.x","article-title":"Lipid-based nanotherapeutics for siRNA delivery","volume":"267","author":"Schroeder","year":"2010","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0430","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnagi.2016.00068","article-title":"Lipopolyplex for therapeutic gene delivery and its application for the treatment of Parkinson's disease","volume":"8","author":"Chen","year":"2016","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0435","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/hmg\/dds496","article-title":"MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastoma","volume":"22","author":"Costa","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0440","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/PPO.0b013e318244d8ae","article-title":"Novel delivery strategies for glioblastoma","volume":"18","author":"Zhou","year":"2012","journal-title":"Cancer J."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0445","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejps.2010.03.019","article-title":"Gene delivery by lipoplexes and polyplexes","volume":"40","author":"Tros de Ilarduya","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0450","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/2277-9175.98152","article-title":"Viral and nonviral delivery systems for gene delivery","volume":"1","author":"Nayerossadat","year":"2012","journal-title":"Adv. Biomed. Res."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0455","doi-asserted-by":"crossref","first-page":"10801","DOI":"10.1021\/acsnano.5b03124","article-title":"GM1-modified lipoprotein-like nanoparticle: multifunctional Nanoplatform for the combination therapy of Alzheimer's disease","volume":"9","author":"Huang","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0460","doi-asserted-by":"crossref","first-page":"17620","DOI":"10.1074\/jbc.M113.476697","article-title":"\u0391-Synuclein oligomers with broken helical conformation form lipoprotein nanoparticles","volume":"288","author":"Varkey","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0465","doi-asserted-by":"crossref","unstructured":"K.M. McMahon, L. Foit, N.L. Angeloni, F.J. Giles, L.I. Gordon, C.S. Thaxton, Synthetic high-density lipoprotein-like nanoparticles as cancer therapy, in: 2015: pp. 129\u2013150. doi:http:\/\/dx.doi.org\/10.1007\/978-3-319-16555-4_6.","DOI":"10.1007\/978-3-319-16555-4_6"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0470","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1021\/nn4058215","article-title":"Lipoprotein-based nanoparticles rescue the memory loss of mice with Alzheimer's disease by accelerating the clearance of amyloid-beta","volume":"8","author":"Song","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0475","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/wnan.1308","article-title":"Learning from biology: synthetic lipoproteins for drug delivery","volume":"7","author":"Huang","year":"2015","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0480","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.brainresrev.2010.05.003","article-title":"Looking at the blood-brain barrier: molecular anatomy and possible investigation approaches","volume":"64","author":"Cardoso","year":"2010","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0485","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/S0140-6736(11)61346-9","article-title":"Primary brain tumours in adults","volume":"379","author":"Ricard","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0490","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.addr.2006.09.012","article-title":"Brain cancer diagnosis and therapy with nanoplatforms\u2606","volume":"58","author":"Koo","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0495","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1001\/archneur.1989.00520420080026","article-title":"Interrater reliability of the nih stroke scale","volume":"46","author":"LB","year":"1989","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0500","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/01376517-200710000-00005","article-title":"Acute ischemic stroke review","volume":"39","author":"Hinkle","year":"2007","journal-title":"J. Neurosci. Nurs."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0505","first-page":"442","article-title":"Pharmacological treatment of Parkinson disease","volume":"311","author":"Connolly Barbara","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0510","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/S0140-6736(05)67889-0","article-title":"Global prevalence of dementia: a Delphi consensus study","volume":"366","author":"Ferri","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0515","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.biopha.2016.12.010","article-title":"Multiple sclerosis: therapeutic applications of advancing drug delivery systems","volume":"86","author":"Dolati","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0520","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1016\/j.biomaterials.2011.01.048","article-title":"Inhibition of human brain malignant glioblastoma cells using carmustine-loaded catanionic solid lipid nanoparticles with surface anti-epithelial growth factor receptor","volume":"32","author":"Kuo","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0525","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.colsurfb.2011.02.011","article-title":"Catanionic solid lipid nanoparticles carrying doxorubicin for inhibiting the growth of U87MG cells","volume":"85","author":"Kuo","year":"2011","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0530","first-page":"32","article-title":"Delivery of doxorubicin to glioblastoma multiforme in vitro using solid lipid nanoparticles with surface aprotinin and melanotransferrin antibody for enhanced chemotherapy, J. Taiwan Inst","volume":"61","author":"Kuo","year":"2015","journal-title":"Chem. Eng."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0535","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1002\/jps.24388","article-title":"Inhibition against growth of glioblastoma multiforme in vitro using etoposide-loaded solid lipid nanoparticles with p-aminophenyl-\u03b1-D-manno-pyranoside and folic acid","volume":"104","author":"Kuo","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0540","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jtice.2014.08.035","article-title":"Carmustine-loaded catanionic solid lipid nanoparticles with serotonergic 1B receptor subtype antagonist for in vitro targeted delivery to inhibit brain cancer growth","volume":"46","author":"Kuo","year":"2015","journal-title":"J. Taiwan Inst. Chem. Eng."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0545","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.lfs.2016.01.025","article-title":"Dual targeting of solid lipid nanoparticles grafted with 83-14 MAb and anti-EGF receptor for malignant brain tumor therapy","volume":"146","author":"Kuo","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0550","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/btpr.2214","article-title":"Conjugation of melanotransferrin antibody on solid lipid nanoparticles for mediating brain cancer malignancy","volume":"32","author":"Kuo","year":"2016","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0555","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijpharm.2015.12.054","article-title":"Brain targeted delivery of carmustine using solid lipid nanoparticles modified with tamoxifen and lactoferrin for antitumor proliferation","volume":"499","author":"Kuo","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0560","doi-asserted-by":"crossref","unstructured":"Y.-C. Kuo, I.-H. Wang, Enhanced delivery of etoposide across the blood-brain barrier to restrain brain tumor growth using melanotransferrin antibody- and tamoxifen-conjugated solid lipid nanoparticles., 2016. doi:http:\/\/dx.doi.org\/10.3109\/1061186X.2015.1132223.","DOI":"10.3109\/1061186X.2015.1132223"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0565","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1080\/10717544.2016.1189465","article-title":"Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?","volume":"23","author":"Qu","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0570","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jconrel.2011.07.030","article-title":"In vitro and in vivo efficacy of edelfosine-loaded lipid nanoparticles against glioma","volume":"156","author":"Estella-Hermoso De Mendoza","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0575","doi-asserted-by":"crossref","first-page":"6676","DOI":"10.1166\/jnn.2011.4235","article-title":"Development and evaluation of nanostructured lipid carriers of cytarabine for treatment of meningeal leukemia","volume":"11","author":"Sharma","year":"2011","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0580","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1021\/bc200406n","article-title":"In vivo specific delivery of c-met siRNA to glioblastoma using cationic solid lipid nanoparticles","volume":"22","author":"Jin","year":"2011","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0585","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ijpharm.2012.03.032","article-title":"Solid lipid nanoparticles as intracellular drug transporters: an investigation of the uptake mechanism and pathway","volume":"430","author":"Martins","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0590","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijpharm.2012.09.054","article-title":"Brain delivery of camptothecin by means of solid lipid nanoparticles: formulation design, in vitro and in vivo studies","volume":"439","author":"Martins","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0595","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ejpb.2013.08.011","article-title":"Brain targeting effect of camptothecin-loaded solid lipid nanoparticles in rat after intravenous administration","volume":"85","author":"Martins","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0600","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/23\/40\/405101","article-title":"Targeting etoposide to acute myelogenous leukaemia cells using nanostructured lipid carriers coated with transferrin","volume":"23","author":"Khajavinia","year":"2012","journal-title":"Nanotechnology"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0605","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ijpharm.2013.05.049","article-title":"Silencing of miR-21 by locked nucleic acid-lipid nanocapsule complexes sensitize human glioblastoma cells to radiation-induced cell death","volume":"454","author":"Griveau","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0610","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ejpb.2012.10.019","article-title":"Curcumin-loaded lipid-core nanocapsules as a strategy to improve pharmacological efficacy of curcumin in glioma treatment","volume":"83","author":"Zanotto-Filho","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0615","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2147\/IJN.S40284","article-title":"The antiproliferative effect of indomethacin-loaded lipid-core nanocapsules in glioma cells is mediated by cell cycle regulation, differentiation, and the inhibition of survival pathways","volume":"8","author":"Bernardi","year":"2013","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0620","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijpharm.2014.08.003","article-title":"In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery","volume":"474","author":"Jose","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0625","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1002\/jps.24002","article-title":"Solid lipid nanoparticles for potential doxorubicin delivery in glioblastoma treatment: Preliminary in vitro studies","volume":"103","author":"Battaglia","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0630","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.ejpb.2014.10.017","article-title":"Positive-charged solid lipid nanoparticles as paclitaxel drug delivery system in glioblastoma treatment","volume":"88","author":"Chirio","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0635","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10717544.2014.975382","article-title":"Curcumin-loaded nanostructured lipid carriers (NLCs) for nasal administration: design, characterization, and in vivo study","volume":"7544","author":"Madane","year":"2014","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0640","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1021\/nn506248s","article-title":"Localized RNAi therapeutics of Chemoresistant grade IV glioma using hyaluronan-grafted lipid-based nanoparticles","volume":"9","author":"Cohen","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0645","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/26\/25\/255102","article-title":"Bevacizumab loaded solid lipid nanoparticles prepared by the coacervation technique: preliminary in vitro studies","volume":"26","author":"Battaglia","year":"2015","journal-title":"Nanotechnology"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0650","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.3109\/10717544.2015.1038857","article-title":"Nanostructured lipid carriers based temozolomide and gene co-encapsulated nanomedicine for gliomatosis cerebri combination therapy","volume":"23","author":"Chen","year":"2015","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0655","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10717544.2015.1028601","article-title":"Containing, temozolomide-loading nanostructured lipid carriers for glioblastoma multiforme chemotherapy","volume":"0","author":"Song","year":"2015","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0660","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.3109\/10717544.2015.1058434","article-title":"Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery","volume":"23","author":"Wu","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0665","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3109\/10717544.2015.1049719","article-title":"Nanostructured lipid carriers enhance the bioavailability and brain cancer inhibitory efficacy of curcumin both in vitro and in vivo","volume":"23","author":"Chen","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0670","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1080\/10837450.2016.1189933","article-title":"Development and optimization of transferrin-conjugated nanostructured lipid carriers for brain delivery of paclitaxel using Box\u2013Behnken design","volume":"22","author":"Emami","year":"2017","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0675","article-title":"Multiplexed RNAi therapy against brain tumor-initiating cells via lipopolymeric nanoparticle infusion delays glioblastoma progression","volume":"201701911","author":"Yu","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0680","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nnano.2014.84","article-title":"In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight","volume":"9","author":"Dahlman","year":"2014","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0685","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijpharm.2010.05.005","article-title":"Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability","volume":"394","author":"Zhuang","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0690","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3109\/10837450.2012.734513","article-title":"Brain targeted solid lipid nanoparticles for brain ischemia: preparation and in vitro characterization","volume":"18","author":"Morsi","year":"2013","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0695","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ijpharm.2014.02.013","article-title":"A novel oral delivery system consisting in \u201cdrug-in cyclodextrin-in nanostructured lipid carriers\u201d for poorly water-soluble drug: Vinpocetine","volume":"465","author":"Lin","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0700","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ejpb.2013.02.005","article-title":"Curcumin loaded solid lipid nanoparticles: an efficient formulation approach for cerebral ischemic reperfusion injury in rats","volume":"85","author":"Kakkar","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0705","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.biomaterials.2013.09.093","article-title":"Targeted therapy of brain ischaemia using Fas ligand antibody conjugated PEG-lipid nanoparticles","volume":"35","author":"mei Lu","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0710","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ijpharm.2011.12.009","article-title":"Baicalein loaded in tocol nanostructured lipid carriers (tocol NLCs) for enhanced stability and brain targeting","volume":"423","author":"Tsai","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0715","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ijpharm.2015.04.049","article-title":"Effect of Baicalin-loaded PEGylated cationic solid lipid nanoparticles modified by OX26 antibody on regulating the levels of baicalin and amino acids during cerebral ischemia-reperfusion in rats","volume":"489","author":"Liu","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0720","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/03639045.2013.861478","article-title":"Preparation and evaluation of Baicalin-loaded cationic solid lipid nanoparticles conjugated with OX26 for improved delivery across the BBB","volume":"41","author":"Liu","year":"2015","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0725","doi-asserted-by":"crossref","first-page":"405101","DOI":"10.1088\/0957-4484\/21\/40\/405101","article-title":"Physicochemical characterization and in vivo bioluminescence imaging of nanostructured lipid carriers for targeting the brain: apomorphine as a model drug","volume":"21","author":"Hsu","year":"2010","journal-title":"Nanotechnology"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0730","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/jps.22285","article-title":"Oral Apomorphine delivery from solid lipid nanoparticles with different Monostearate emulsifiers: pharmacokinetic and behavioral evaluations","volume":"100","author":"Tsai","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0735","doi-asserted-by":"crossref","first-page":"95103","DOI":"10.1088\/0957-4484\/23\/9\/095103","article-title":"Combined strategies of apomorphine diester prodrugs and nanostructured lipid carriers for efficient brain targeting","volume":"23","author":"Liu","year":"2012","journal-title":"Nanotechnology"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0740","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1007\/s10856-013-4965-7","article-title":"Novel surface modified polymer-lipid hybrid nanoparticles as intranasal carriers for ropinirole hydrochloride: in vitro, ex vivo and in vivo pharmacodynamic evaluation","volume":"24","author":"Pardeshi","year":"2013","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0745","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ijpharm.2014.07.025","article-title":"Effect of surface charge on the brain delivery of nanostructured lipid carriers in situ gels via the nasal route","volume":"473","author":"Gabal","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0750","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.nano.2013.10.009","article-title":"Gelatin nanostructured lipid carriers-mediated intranasal delivery of basic fibroblast growth factor enhances functional recovery in hemiparkinsonian rats","volume":"10","author":"Zhao","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0755","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1248\/cpb.58.656","article-title":"Preparation, optimization and characteristic of huperzine a loaded nanostructured lipid carriers","volume":"58","author":"Yang","year":"2010","journal-title":"Chem. Pharm. Bull. (Tokyo)."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0760","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ijpharm.2013.02.014","article-title":"Comparative in vitro and in vivo evaluation of lipid based nanocarriers of Huperzine A","volume":"446","author":"Patel","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0765","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.2042-7158.2010.01225.x","article-title":"Formulation development and systematic optimization of solid lipid nanoparticles of quercetin for improved brain delivery","volume":"63","author":"Dhawan","year":"2011","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0770","doi-asserted-by":"crossref","first-page":"6519","DOI":"10.1016\/j.biomaterials.2010.04.044","article-title":"Lipid-based nanoparticles with high binding affinity for amyloid-\u03b21-42 peptide","volume":"31","author":"Gobbi","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0775","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3109\/1061186X.2012.747529","article-title":"Preparation, characterization, in vivo and biochemical evaluation of brain targeted Piperine solid lipid nanoparticles in an experimentally induced Alzheimer's disease model","volume":"21","author":"Yusuf","year":"2013","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0780","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.colsurfb.2015.06.025","article-title":"A novel LDL-mimic nanocarrier for the targeted delivery of curcumin into the brain to treat Alzheimer's disease","volume":"134","author":"Meng","year":"2015","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0785","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ijpharm.2015.03.001","article-title":"Solid lipid nanoparticles loaded with lipoyl-memantine codrug: preparation and characterization","volume":"485","author":"Laserra","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0790","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejphar.2014.11.014","article-title":"Neuroprotective potential of sesamol and its loaded solid lipid nanoparticles in ICV-STZ-induced cognitive deficits: behavioral and biochemical evidence","volume":"747","author":"Sachdeva","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0795","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.npep.2016.03.002","article-title":"Mitigating effect of chrysin loaded solid lipid nanoparticles against amyloid \u03b225\u201335 induced oxidative stress in rat hippocampal region: an efficient formulation approach for Alzheimer's disease","volume":"58","author":"Vedagiri","year":"2016","journal-title":"Neuropeptides"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0800","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2217\/nnm.09.67","article-title":"Brain-targeted solid lipid nanoparticles containing riluzole: preparation, characterization and biodistribution","volume":"5","author":"Bond\u00ec","year":"2010","journal-title":"Nanomedicine (London)"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0805","doi-asserted-by":"crossref","DOI":"10.1080\/10837450.2016.1226901","article-title":"Solid lipid nanoparticles surface modified with anti-Contactin-2 or anti-Neurofascin for brain-targeted delivery of medicines","volume":"22","author":"Gandomi","year":"2017","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0810","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ijpharm.2011.05.044","article-title":"Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: comparative analysis of characteristics, pharmacokinetics and tissue uptake","volume":"415","author":"Tiwari","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0815","first-page":"363","article-title":"Brain delivery of valproic acid via intranasal administration of nanostructured lipid carriers: in vivo pharmacodynamic studies using rat electroshock model","volume":"6","author":"Eskandari","year":"2011","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0820","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ijpharm.2012.03.042","article-title":"Development of a quercetin-loaded nanostructured lipid carrier formulation for topical delivery","volume":"430","author":"Guo","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0825","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijpharm.2012.12.013","article-title":"Formulation optimization and topical delivery of quercetin from solid lipid based nanosystems","volume":"441","author":"Bose","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0830","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.colsurfb.2013.11.029","article-title":"Characterization and biodistribution in vivo of quercetin-loaded cationic nanostructured lipid carriers","volume":"115","author":"Liu","year":"2014","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0835","doi-asserted-by":"crossref","first-page":"5395","DOI":"10.2147\/IJN.S36257","article-title":"In vitro characterization and in vivo evaluation of nanostructured lipid curcumin carriers for intragastric administration","volume":"7","author":"Fang","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.08.033_bb0840","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ijpharm.2013.03.046","article-title":"Proof of concept studies to confirm the delivery of curcumin loaded solid lipid nanoparticles (C-SLNs) to brain","volume":"448","author":"Kakkar","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0845","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijpharm.2016.04.033","article-title":"Design and evaluation of lipoprotein resembling curcumin-encapsulated protein-free nanostructured lipid carrier for brain targeting","volume":"506","author":"Meng","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0850","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3109\/03639045.2010.539231","article-title":"In vitro evaluation of idebenone-loaded solid lipid nanoparticles for drug delivery to the brain","volume":"37","author":"Montenegro","year":"2011","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0855","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1021\/mp300149w","article-title":"Idebenone loaded solid lipid nanoparticles interact with biomembrane models: calorimetric evidence","volume":"9","author":"Montenegro","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0860","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.4155\/tde.13.101","article-title":"Assessment of novel iloperidone- and idebenone-loaded nanostructured lipid carriers: brain targeting efficiency and neuroprotective potential","volume":"4","author":"Mandpe","year":"2013","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0865","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3109\/10837450.2014.915572","article-title":"Antioxidant activity of idebenone-loaded neutral and cationic solid\u2013lipid nanoparticles","volume":"20","author":"Leonardi","year":"2015","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0870","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejpb.2011.02.009","article-title":"Baclofen-loaded solid lipid nanoparticles: preparation, electrophysiological assessment of efficacy, pharmacokinetic and tissue distribution in rats after intraperitoneal administration","volume":"79","author":"Priano","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0875","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3109\/1061186X.2010.523787","article-title":"Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route","volume":"19","author":"Patel","year":"2011","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0880","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.ijpharm.2012.07.058","article-title":"Long-term stability, biocompatibility and oral delivery potential of risperidone-loaded solid lipid nanoparticles","volume":"436","author":"Silva","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0885","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1039\/C5RA19793G","article-title":"Intranasal delivery of asenapine loaded nanostructured lipid carriers: formulation, characterization, pharmacokinetic and behavioural assessment","volume":"6","author":"Singh","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0890","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.jpsychires.2012.05.014","article-title":"Intranasal administration of nanostructured lipid carriers containing CNS acting drug: pharmacodynamic studies and estimation in blood and brain","volume":"46","author":"Alam","year":"2012","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0895","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3109\/1061186X.2014.940589","article-title":"Preparation and characterization of photo-responsive cell-penetrating peptide-mediated nanostructured lipid carrier","volume":"22","author":"Yang","year":"2014","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2017.08.033_bb0900","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s40089-015-0161-8","article-title":"Development of nanostructured lipid carrier for dacarbazine delivery","volume":"5","author":"Almousallam","year":"2015","journal-title":"Int. Nano Lett."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917308155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917308155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T10:56:03Z","timestamp":1602845763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365917308155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":180,"alternative-id":["S0168365917308155"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.08.033","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.08.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}